Learn About Simply Safe Dividends

Try It Free!

[/fusion_text]

These are our most recent articles. Also see which stocks have been this week’s best and worst performers.

Johnson & Johnson: A Dependable Dividend King for the Long Term

Founded in 1885, Johnson & Johnson (JNJ) is the world’s largest medical conglomerate. With more than 250 subsidiaries operating in over 60 countries, Johnson & Johnson’s three major business units provide it with a diversified mix of revenue, earnings, and cash flow. Here are the company’s operating segments: Pharmaceuticals (50% of sales, 61% of pretax profits): dozens of patented drugs and vaccines to treat oncology, cardiovascular, immunological, neurological, and infectious diseases, and diabetes. Remicade, a treatment for a number of immune-mediated inflammatory diseases, is Johnson & Johnson’s largest drug and accounted for 6.5% of company-wide revenue in 2018. Medical Devices (33% of sales, 29% of pretax profits): surgical, orthopedic, endomechanical (i.e. hip replacements), and sterilization equipment. Consumer Products (17% of sales, 10% [...]

February 12th, 2019|

Pfizer: One of the Best Dividend Stocks in Pharma

Founded in 1849, Pfizer (PFE) is one of the world's largest drugmakers, with medications sold in over 125 countries. The company's annual sales exceed $50 billion and are grouped into three business segments: Pfizer Biopharmaceuticals (56% of sales): produces patented medicines to treat various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases. This unit drives Pfizer's overall growth because it produces all of the company's largest sellers, including a number of medications with more than $1 billion in annual sales. Compared to other pharma and biotech companies, Pfizer's portfolio is nicely diversified by treatment area and drug type, reducing its risk profile.

February 8th, 2019|

Top 10 Recession Proof Dividend Aristocrats

Many investors desire to live off safe and growing dividends during retirement, allowing them to worry less about stock market fluctuations and recessions. To this end, many blue-chip dividend stocks have impressive track records of not only maintaining or growing their payouts during market downturns, but also outperforming the broader market. Dividend aristocrats, S&P 500 companies that have increased their payouts for at least 25 consecutive years, are an appealing place to start looking for recession-proof stocks that can deliver safe and growing income during any economic, interest rate, or stock market environment.

February 7th, 2019|

Gilead’s Dividend is Solid, But Growth Challenges Linger

Founded in 1987, Gilead Sciences (GILD) is one of the world's leading biotech companies. The firm operates in more than 35 countries worldwide, researching, manufacturing, and distributing various medications to treat HIV/AIDs, liver diseases, and immune, respiratory, and cardiovascular diseases. Gilead has historically focused on antiviral products for infectious diseases, which made up 84% of sales in 2018

February 6th, 2019|
Load More Posts